MARC SCHEGERIN - 12 Jan 2024 Form 4 Insider Report for Morphic Holding, Inc.

Role: CFO and COO
Signature: /s/ Robert Farrell as attorney-in-fact for Marc M.D. Schegerin
Issuer symbol: N/A
Transactions as of: 12 Jan 2024
Net transactions value: -$166,071
Form type: 4
Filing time: 17 Jan 2024, 19:03:36 UTC
Previous filing: 08 Sep 2023
Next filing: 10 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MORF	Common Stock	Options Exercise	$0	+14,675	+61%	$0.000000	38,811	13 Jan 2024	Direct	F1
transaction	MORF	Common Stock	Options Exercise	$0	+4,690	+12%	$0.000000	43,501	14 Jan 2024	Direct	F1
transaction	MORF	Common Stock	Sale	$166,071	-6,041	-14%	$27.49	37,460	16 Jan 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MORF	Stock Option (right to buy Common Stock)	Award	$0	+133,200		$0.000000	133,200	12 Jan 2024	Common Stock	133,200	$27.79	Direct	F3
transaction	MORF	Restricted Stock Unit	Award	$0	+85,800		$0.000000	85,800	12 Jan 2024	Common Stock	85,800		Direct	F1, F4
transaction	MORF	Restricted Stock Unit	Options Exercise	$0	-14,675	-25%	$0.000000	44,025	13 Jan 2024	Common Stock	14,675		Direct	F1, F5
transaction	MORF	Restricted Stock Unit	Options Exercise	$0	-4,690	-33%	$0.000000	9,380	14 Jan 2024	Common Stock	4,690		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2	The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F3	The option vests as to 2.0833% of the total shares monthly, beginning February 12, 2024, with 100% of the total shares vested and exercisable on January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
F4	The RSUs vest as to 25% of the total shares on each of January 12, 2025, January 12, 2026, January 12, 2027 and January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
F5	The RSUs vest as to 25% of the total shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
F6	The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025 and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.